HSBC Holdings’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-10,676
Closed -$1.07M 2184
2014
Q4
$1.07M Buy
10,676
+3,090
+41% +$240K ﹤0.01% 1309
2014
Q3
$504K Sell
7,586
-3,763
-33% -$247K ﹤0.01% 1467
2014
Q2
$792K Sell
11,349
-997
-8% -$67.8K ﹤0.01% 1365
2014
Q1
$903K Sell
12,346
-868
-7% -$64.7K ﹤0.01% 1257
2013
Q4
$909K Buy
13,214
+393
+3% +$25.4K ﹤0.01% 1292
2013
Q3
$815K Buy
12,821
+3,774
+42% +$228K ﹤0.01% 1277
2013
Q2
$437K Buy
+9,047
New +$445K ﹤0.01% 1231

HSBC Holdings's CBST Position: Q1 2015 in Review

HSBC Holdings sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 10,676 shares — an estimated $1.07M sold.

HSBC Holdings first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $1.07M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • HSBC Holdings reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • HSBC Holdings sold 10,676 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.07M.
  • HSBC Holdings first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • HSBC Holdings's CUBIST PHARMACEUTICALS INC position peaked at $1.07M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on HSBC Holdings's 13F filing for Q1 2015, filed 14 May 2015.